• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

实验性恶性高血压中的血浆免疫反应性内皮素-1

Plasma immunoreactive endothelin-1 in experimental malignant hypertension.

作者信息

Kohno M, Murakawa K, Horio T, Yokokawa K, Yasunari K, Fukui T, Takeda T

机构信息

First Department of Internal Medicine, Osaka City University Medical School, Japan.

出版信息

Hypertension. 1991 Jul;18(1):93-100. doi: 10.1161/01.hyp.18.1.93.

DOI:10.1161/01.hyp.18.1.93
PMID:1860718
Abstract

We measured plasma concentrations of immunoreactive endothelin-1 (irET-1) in the prehypertensive and hypertensive phases in spontaneously hypertensive rats (SHR) and in malignant hypertension caused by deoxycorticosterone acetate (DOCA)-salt administration in SHR. We also measured concentrations of this peptide in another model of malignant hypertension, the two-kidney, one clip (2K1C) renovascular hypertensive rats chronically given caffeine. Plasma irET-1 concentrations in young (6-week-old) and mature (18-week-old) SHR did not differ from those of age-matched Wistar-Kyoto (WKY) rats. Four weeks of treatment with DOCA-salt increased blood pressure, blood urea nitrogen, serum creatinine, and plasma irET-1 in SHR but not in WKY rats. Eight weeks of DOCA-salt treatment further increased these values in SHR. Plasma irET-1 concentrations were not increased in the 2K1C rats. Six weeks of caffeine administration increased blood pressure, blood urea nitrogen, serum creatinine, plasma renin activity, and plasma irET-1 in the 2K1C rats but not in the sham-operated rats. High-performance liquid chromatographic profiles of plasma extracts pooled from these rats with malignant hypertension showed that a major component of irET-1 eluted in the position of synthetic ET-1 (1-21). Furthermore, acute hypertension induced by angiotensin II or phenylephrine did not affect the plasma irET-1 concentration in rats. The results suggested that the plasma ET-1 concentration is increased in rat models of malignant hypertension and that the high blood pressure itself is not the main factor involved in the increase of plasma ET-1.

摘要

我们测量了自发性高血压大鼠(SHR)高血压前期和高血压期以及通过给SHR注射醋酸脱氧皮质酮(DOCA)-盐诱导的恶性高血压中免疫反应性内皮素-1(irET-1)的血浆浓度。我们还测量了另一种恶性高血压模型——长期给予咖啡因的两肾一夹(2K1C)肾血管性高血压大鼠中该肽的浓度。年轻(6周龄)和成熟(18周龄)SHR的血浆irET-1浓度与年龄匹配的Wistar-Kyoto(WKY)大鼠的浓度无差异。DOCA-盐治疗4周使SHR的血压、血尿素氮、血清肌酐和血浆irET-1升高,但WKY大鼠未出现此情况。DOCA-盐治疗8周使SHR的这些值进一步升高。2K1C大鼠的血浆irET-1浓度未升高。给予咖啡因6周使2K1C大鼠的血压、血尿素氮、血清肌酐、血浆肾素活性和血浆irET-1升高,但假手术大鼠未出现此情况。从这些患有恶性高血压的大鼠中收集的血浆提取物的高效液相色谱图谱显示,irET-1的主要成分在合成ET-1(1-21)的位置洗脱。此外,血管紧张素II或去氧肾上腺素诱导的急性高血压不影响大鼠的血浆irET-1浓度。结果表明,在大鼠恶性高血压模型中血浆ET-1浓度升高,且高血压本身不是血浆ET-1升高的主要因素。

相似文献

1
Plasma immunoreactive endothelin-1 in experimental malignant hypertension.实验性恶性高血压中的血浆免疫反应性内皮素-1
Hypertension. 1991 Jul;18(1):93-100. doi: 10.1161/01.hyp.18.1.93.
2
Renoprotective effects of a combined endothelin type A/type B receptor antagonist in experimental malignant hypertension.一种内皮素A/B型受体联合拮抗剂在实验性恶性高血压中的肾脏保护作用。
Metabolism. 1997 Sep;46(9):1032-8. doi: 10.1016/s0026-0495(97)90274-2.
3
Accelerated secretion of brain natriuretic peptide from the hypertrophied ventricles in experimental malignant hypertension.实验性恶性高血压中肥厚心室脑钠肽分泌加速。
Hypertension. 1992 Feb;19(2):206-11. doi: 10.1161/01.hyp.19.2.206.
4
Effect of chronic ETA-selective endothelin receptor antagonism on blood pressure in experimental and genetic hypertension in rats.慢性ETA选择性内皮素受体拮抗剂对大鼠实验性高血压和遗传性高血压血压的影响。
Br J Pharmacol. 1997 Jul;121(5):935-40. doi: 10.1038/sj.bjp.0701224.
5
Serial renin-angiotensin studies in spontaneously hypertensive and Wistar-Kyoto normotensive rats. Transition from normal- to high-renin status during the established phase of spontaneous hypertension.对自发性高血压大鼠和Wistar-Kyoto正常血压大鼠进行的系列肾素-血管紧张素研究。在自发性高血压的已确立阶段从正常肾素状态向高肾素状态的转变。
Hypertension. 1979 Jul-Aug;1(4):347-54. doi: 10.1161/01.hyp.1.4.347.
6
DOCA-salt induced malignant hypertension in spontaneously hypertensive rats.
J Hypertens. 1984 Feb;2(1):49-54. doi: 10.1097/00004872-198402000-00009.
7
Antihypertensive effect of an endothelin receptor antagonist in DOCA-salt spontaneously hypertensive rats.内皮素受体拮抗剂对去氧皮质酮盐诱导的自发性高血压大鼠的降压作用。
Br J Pharmacol. 1995 Aug;115(8):1377-81. doi: 10.1111/j.1476-5381.1995.tb16626.x.
8
Long-term adrenomedullin infusion improves survival in malignant hypertensive rats.长期输注肾上腺髓质素可提高恶性高血压大鼠的存活率。
Hypertension. 2002 Jul;40(1):107-13. doi: 10.1161/01.hyp.0000023226.50264.42.
9
Effect of an antihypertensive drug on brain angiotensin II levels in renal and spontaneously hypertensive rats.
Clin Exp Pharmacol Physiol. 1995 Sep;22(9):665-9. doi: 10.1111/j.1440-1681.1995.tb02085.x.
10
Protective effects of the angiotensin II type 1 (AT1) receptor blockade in low-renin deoxycorticosterone acetate (DOCA)-treated spontaneously hypertensive rats.血管紧张素II 1型(AT1)受体阻断对低肾素醋酸脱氧皮质酮(DOCA)处理的自发性高血压大鼠的保护作用。
Clin Sci (Lond). 2004 Mar;106(3):251-9. doi: 10.1042/CS20030299.

引用本文的文献

1
Endothelin-1 in Health and Disease.内皮素-1 在健康与疾病中的作用
Int J Mol Sci. 2023 Jul 10;24(14):11295. doi: 10.3390/ijms241411295.
2
Endothelin-1 axes in the framework of predictive, preventive and personalised (3P) medicine.预测、预防和个性化(3P)医学框架下的内皮素-1轴
EPMA J. 2021 Aug 4;12(3):265-305. doi: 10.1007/s13167-021-00248-z. eCollection 2021 Sep.
3
Downregulation of Renal G Protein-Coupled Receptor Kinase Type 4 Expression via Ultrasound-Targeted Microbubble Destruction Lowers Blood Pressure in Spontaneously Hypertensive Rats.
通过超声靶向微泡破坏下调肾脏G蛋白偶联受体激酶4的表达可降低自发性高血压大鼠的血压。
J Am Heart Assoc. 2016 Oct 6;5(10):e004028. doi: 10.1161/JAHA.116.004028.
4
Pyk2 mediates increased adrenergic contractile responses in arteries from DOCA-salt mice - VASOACTIVE PEPTIDE SYMPOSIUM.Pyk2介导去氧皮质酮盐(DOCA)-盐处理小鼠动脉中肾上腺素能收缩反应增强——血管活性肽研讨会
J Am Soc Hypertens. 2008 Nov-Dec;2(6):431-8. doi: 10.1016/j.jash.2008.05.001.
5
Modeling and docking the endothelin G-protein-coupled receptor.内皮素G蛋白偶联受体的建模与对接
Biophys J. 2000 Dec;79(6):3083-94. doi: 10.1016/S0006-3495(00)76543-X.
6
Endothelial dysfunction and hypertension.内皮功能障碍与高血压。
Drugs. 1997;53 Suppl 1:30-41. doi: 10.2165/00003495-199700531-00006.
7
Systemic hypertension induced by hepatic overexpression of human preproendothelin-1 in rats.人前内皮素-1在大鼠肝脏中过表达诱导的系统性高血压
J Clin Invest. 1996 Nov 15;98(10):2364-72. doi: 10.1172/JCI119049.
8
The clinical potential of endothelin receptor antagonists in cardiovascular medicine.内皮素受体拮抗剂在心血管医学中的临床潜力。
Drugs. 1996 Jan;51(1):12-27. doi: 10.2165/00003495-199651010-00003.
9
Blood pressure regulates platelet-derived growth factor A-chain gene expression in vascular smooth muscle cells in vivo. An autocrine mechanism promoting hypertensive vascular hypertrophy.血压在体内调节血管平滑肌细胞中血小板衍生生长因子A链基因的表达。一种促进高血压性血管肥大的自分泌机制。
J Clin Invest. 1995 Mar;95(3):1140-50. doi: 10.1172/JCI117762.
10
Role of endothelin-1 and the ETA receptor in the maintenance of deoxycorticosterone acetate-salt-induced hypertension.内皮素-1及内皮素A受体在维持醋酸脱氧皮质酮-盐诱导的高血压中的作用
Br J Pharmacol. 1995 Mar;114(5):925-30. doi: 10.1111/j.1476-5381.1995.tb13292.x.